Clinical Trial: A Study to Evaluate Single and Multiple Doses of SEP-479 in Healthy Adult Participants

U.S., Feb. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07433179) titled 'A Study to Evaluate Single and Multiple Doses of SEP-479 in Healthy Adult Participants' on Feb. 19.

Brief Summary: The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and food effects of oral SEP-479 in healthy adult participants.

Study Start Date: March, 2026

Study Type: INTERVENTIONAL

Condition: Healthy Volunteers

Intervention: DRUG: SEP-479

Oral, capsule

OTHER: Placebo

Oral, capsule

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Septerna, Inc.

Published by HT Digital Content Services with permission from Health Daily Digest....